Parnian Arjmand MD

Uczestniczy w 3 elementy

Elementy, w których Parnian Arjmand MD uczestniczy

sobota 27 czerwiec, 2020

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
14:20
Geographic Atrophy in the Canadian Treat and Extent Trial with Ranibizumab in patients with nAMD
14:20 - 14:30 | 10 min.

piątek 20 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
15:10
Aflibercept 8 mg versus 2 mg: Intraocular Pressure Changes in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema - 5456
Vancouver Convention Centre (East Building) - Ballroom B
15:12 - 15:17 | 5 min.

Author’s Name(s): Parnian Arjmand, Ramin Khoramnia, Paolo Lanzetta, Anat Loewenstein, Michael Stewart, Richard Gale, Marion Munk, Ursula Schmidt-Ott, April McCullough, Claudia Tueckmantel, Alyson BerlinerAuthor’s Disclosure Block: Parnian Arjmand: Hoffman La Roche, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Apobiologix, Employment/honoraria/consulting fees, Young MDConnect, Employment/honoraria/consulting fees; R...

15:15
Q&A
Vancouver Convention Centre (East Building) - Ballroom B
15:17 - 15:20 | 3 min.